Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.81 USD | -0.01% | +6.58% | +42.11% |
May. 14 | Viracta Therapeutics Appoints Michael Faerm CFO | MT |
May. 14 | Viracta Therapeutics, Inc. Appoints Michael Faerm as Chief Financial Officer | CI |
- Stock Market
- Equities
- VIRX Stock
- News Viracta Therapeutics, Inc.